In addition, a number of BK channel openers are currently in development (Webb et al., 2015); however, the use of BK channel openers for the treatment of hypertension is limited by concerns for off-site effects in other smooth muscle tissues. The gene discussed is KCNMA1; the disease is Hypertension.